Active Ingredient History
Cefixime, an antibiotic, is a third-generation cephalosporin like ceftriaxone and cefotaxime. Cefixime is highly stable in the presence of beta-lactamase enzymes. As a result, many organisms resistant to penicillins and some cephalosporins due to the presence of beta-lactamases, may be susceptible to cefixime. The antibacterial effect of cefixime results from inhibition of mucopeptide synthesis in the bacterial cell wall. Like all beta-lactam antibiotics, cefixime binds to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, causing the inhibition of the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefixime interferes with an autolysin inhibitor. Cefixime is sold under the brand name Suprax, indicated for the treatment of: Uncomplicated Urinary Tract Infections Otitis Media Pharyngitis and Tonsillitis Acute Exacerbations of Chronic Bronchitis Uncomplicated Gonorrhea (cervical/urethral) NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Bronchitis, Chronic (approved 1989)
Gonorrhea (approved 1989)
Urinary Tract Infections (approved 1989)
Bacterial Infections (Phase 4)
Chlamydia (Phase 2)
Dental Pulp (Phase 2/Phase 3)
Diarrhea (Phase 1)
Gonorrhea (Phase 4)
HIV (Phase 3)
Kidney Diseases (Phase 3)
Liver Abscess (Phase 3)
Neoplasms (Phase 1)
Neuroblastoma (Phase 1)
Pain, Postoperative (Phase 2/Phase 3)
Renal Insufficiency, Chronic (Phase 3)
Syphilis (Phase 3)
Typhoid Fever (Phase 4)
Urinary Bladder, Neurogenic (Phase 4)
Urinary Tract Infections (Phase 4)
Uterine Cervicitis (Phase 3)
Vaginosis, Bacterial (Phase 3)
Vesico-Ureteral Reflux (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue